The U.S. Drug Enforcement Administration (DEA) announced it will publish the Final Rule moving hydrocodone combination products (HCPs) from Schedule III to Schedule II tomorrow in the Federal Register.
The Food and Drug Administration (FDA) has issued an alert regarding an ingredient commonly found in gluten-free products that may cause anaphylaxis in patients with a legume allergy.
The Food and Drug Administration (FDA) is warning consumers not to purchase or use products sold online claiming to prevent or treat the Ebola virus.
Baxter announced a voluntary recall of 2 lots of Dianeal Low Calcium (2.5mEq/L) Peritoneal Dialysis Solution with 2.5% Dextrose 5000mL (Ambu-Flex II).
The Food and Drug Administration (FDA) is advising consumers to not buy or use Arize and Herbal Vigor Quick Fix, products marketed for sexual enhancement.
Regeneca announced a voluntary nationwide recall of its RegenESlim appetite control dietary supplement.
Cubist announced a voluntary recall of certain lots of Cubicin (daptomycin for injection) to the user level due to potential presence of glass particulate matter in vials.
Hospira announced a voluntary recall of one lot of Lidocaine HCl Injection, 2% due to a report of discolored solution with visible particles.
GE Healthcare announced a Class I recall of Single-Width Airway Modules (E-MiniC), and Accessories and Extension Modules (N-FC, N-FCREC).
The FDA is alerting healthcare professionals and consumers of a voluntary recall of all non-expired drug products for sterile use by Unique Pharmaceuticals, as they may be contaminated.